PMC:7161517 / 25690-25807 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T71","span":{"begin":76,"end":79},"obj":"Body_part"}],"attributes":[{"id":"A71","pred":"uberon_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T128","span":{"begin":108,"end":116},"obj":"Disease"}],"attributes":[{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T286","span":{"begin":76,"end":79},"obj":"Chemical"},{"id":"T287","span":{"begin":80,"end":90},"obj":"Chemical"}],"attributes":[{"id":"A286","pred":"chebi_id","subj":"T286","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"},{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T156","span":{"begin":0,"end":117},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T826","span":{"begin":80,"end":90},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T827","span":{"begin":108,"end":116},"obj":"SP_7"},{"id":"T22150","span":{"begin":7,"end":11},"obj":"G_3;PG_10;PR:000003622"},{"id":"T49602","span":{"begin":31,"end":36},"obj":"NCBITaxon:10239"},{"id":"T68685","span":{"begin":97,"end":102},"obj":"NCBITaxon:10239"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1101","span":{"begin":94,"end":102},"obj":"Species"},{"id":"1121","span":{"begin":108,"end":116},"obj":"Disease"}],"attributes":[{"id":"A1101","pred":"tao:has_database_id","subj":"1101","obj":"Tax:9606"},{"id":"A1121","pred":"tao:has_database_id","subj":"1121","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Currently, there is no data to support any conclusive effects of the use of RAS inhibitors in patients with COVID-19."}